VoicePort provides a suite of solutions, including SYNCHRO-SCRIPT, for medication synchronization and a platform for integrated immunization services, among others, that can help pharmacies with data integration, analytics and operational expertise.
The new drug is indicated as a once-daily adjunctive treatment for Type 2 diabetes and works by increasing hormones that stimulate insulin production in the pancreas and that stimulate the liver to produce less glucose.
Hamacher Resource Group will examine the shift in our healthcare system from a professional healthcare setting to self-management and home-based care in the first of two upcoming GMDC Infocasts on Thursday, June 2, from 1 p.m. to 2 p.m., EDT.
The Economic Times is reporting that drugmaker Sun Pharma recently received a subpoena from the Department of Justice looking for information about its U.S. subsidiary’s practices in selling and marketing the company’s generics. The report noted that this is the latest move in a larger regulatory interest in generic drug prices in the last year. (Economic Times)
The Washington Post is reporting that researches have identified a strain of E. coli in a Pennsylvania woman that is resistant to the last-resort antibiotic colistin. Centers for Disease Control and Prevention director Tom Frieden told the Post, “It basically shows us that the end of the road isn’t very far away for antibiotics — that we may be in a situation where we have patients in our intensive care units, or patients getting urinary-tract infections for which we do not have antibiotics.” (Washington Post)
The NCPA 2016 Congressional Pharmacy Summit facilitated more than 600 visits to Capitol Hill by community pharmacists to call on more than 250 representatives and senators to support patient- and pharmacist-friendly legislation.
Forbes is reporting on Circadian Design, a startup that just launched a service called Round Refill, which delivers prescriptions and vitamins in a smart bottle that connects to an app that reminds patients when to take their pills. According to the report, Round Refill is currently open for preorder and it plans to launch next year. (Forbes)
CVS Health’s efforts to dispense opioid overdose reversal drug naloxone without a prescription has already come to 23 states and the company has announced plans to expand to seven more over the course of the summer.
With a little more than a month before McKesson ideaShare 2016, McKesson is highlighting the ways that the event, held at McCormick Place in Chicago from June 26-29 can help pharmacists deliver better outcomes for their patients while expanding their businesses and driving profits.